<DOC>
	<DOC>NCT01381055</DOC>
	<brief_summary>The purpose of this study is to determine whether pentoxifylline associated to pentavalent antimony has a higher cure rate than pentavalent antimony alone in the treatment of cutaneous leishmaniasis.</brief_summary>
	<brief_title>Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis</brief_title>
	<detailed_description />
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis, Cutaneous</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<mesh_term>Meglumine antimoniate</mesh_term>
	<criteria>Newly diagnosed (untreated) cutaneous leishmaniasis with localized lesions and a positive culture or diagnosed by polymerase chain reaction (PCR) methods or by intradermal skin testing (Montenegro test). Number of lesions: 1 to 3 ulcerative lesions. LesionÂ´s diameter: 1 to 5 cm. Disease duration: up to three months. Safety concerns: AST, ALT &gt;3 times upper limit of normal range Serum creatinine or BUN &gt;1.5 times upper limit of normal range Evidence of serious underlying disease (cardiac, renal, hepatic or pulmonary) Immunodeficiency or antibody to HIV Any noncompensated or uncontrolled condition, such as active tuberculosis, malignant disease, severe malaria, HIV, or other major infectious diseases Lactation, pregnancy (to be determined by adequate test) or inadequate contraception in females of childbearing potential for treatment period plus 2 months Lack of suitability for the trial: Negative parasitology (aspirate/biopsy/PCR)or negative Montenegro test Any history of prior antileishmania therapy Any condition which compromises ability to comply with the study procedures Administrative reasons: Lack of ability or willingness to give informed consent (patient and/or parent / legal representative) Anticipated nonavailability for study visits/procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Cutaneous leishmaniasis</keyword>
	<keyword>Pentoxifylline</keyword>
	<keyword>Meglumine antimoniate</keyword>
	<keyword>L. braziliensis</keyword>
</DOC>